FibroBiologics is planning a prospective, multicenter, open-label clinical trial evaluating the safety, tolerability, and efficacy of CYWC628 in treating refractory diabetic foot ulcers with up to 12 ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...

Avoid unnecessary tests and antibiotics by applying evidence-based, cost-conscious infectious-disease decision-making, with ...

LOS ANGELES, CA / ACCESS Newswire / March 9, 2026 / Advanced mobile wound care specialists supporting hospitals, skilled nursing facilities, home health agencies, and patients across Los Angeles, Oran ...

Changes to a key component of the Patient Driven Payment Model remain in limbo two years after they were first proposed, but federal regulators are still poised to refine the system to accommodate for ...

In addition, body temperature measurements via wearables have been shown to help in preventative treatment across a wide range of conditions, for example the prevention of foot ulcers in diabetes ...

Novel artificial intelligence research at New Jersey Institute of Technology, funded by a $40,000 grant from the American ...

Cynthia and Reginald V. Kelly face multiple charges relating to alleged abuse and neglect of vulnerable adults at Park Circle care facility they operated.

The way we see, hear, and interact with the world in our day-to-day lives can be very different from how others experience it ...

There's something profoundly captivating about the phrase "lost to time." Throughout history, countless treasures, cities, ...

A team of University of Mississippi researchers is developing a way to use 3D-printed medicated patches to help close ...

MediWound (NASDAQ:MDWD) executives said 2025 marked a “pivotal year” for the company, highlighting progress in its late-stage EscharEx chronic wound program and the completion of an expanded ...